Industry Calls For EU Action Against French Off-Label Law
This article was originally published in Scrip
Executive Summary
The European pharmaceutical industry has filed a second complaint with the European Commission against national legislation allowing the off-label use of cheaper medicines where approved alternatives exist, for purely financial reasons.